Effects of acute and chronic administration of phencyclidine on the levels of dopamine and metabolites in discrete brain areas of mouse

Toshitaka Nabeshima, M. Hiramatsu, M. Amano

研究成果: Article

9 引用 (Scopus)

抄録

The effects of phencyclidine (PCP) on the levels of dopamine (DA) and metabolites in discrete brain areas of mouse were investigated. In acute experiment, PCP significantly decreased the level of DOPAC but increased that of HVA in the striatum 60 min after the administration. PCP also increased the HVA level in the midbrain and cortex in a dose dependent fashion 60 min after the injection. On the other hand, chronic treatment of PCP produced a significant increase of the striatal DA level but 24 and 48 hr withdrawal from PCP decreased the DOPAC levels in the striatum and cortex. In the midbrain, the DA level was decreased but HVA level was significantly increased in the chronic PCP treated group. However, the increment of HVA levels in the acute experiment was no longer observed in the striatum and cortex. These results suggest that the pharmacological actions of PCP and tolerance development to PCP may be related to the functional changes of dopaminergic neuronal activity.

元の言語English
ページ(範囲)273-287
ページ数15
ジャーナルResearch Communications in Substances of Abuse
4
発行部数4
出版物ステータスPublished - 01-01-1983
外部発表Yes

Fingerprint

Phencyclidine
3,4-Dihydroxyphenylacetic Acid
Dopamine
Mesencephalon
Brain
Corpus Striatum
Pharmacology
Injections
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)

これを引用

@article{04cebbe82c1d4d2696a8e7e5fd18eef6,
title = "Effects of acute and chronic administration of phencyclidine on the levels of dopamine and metabolites in discrete brain areas of mouse",
abstract = "The effects of phencyclidine (PCP) on the levels of dopamine (DA) and metabolites in discrete brain areas of mouse were investigated. In acute experiment, PCP significantly decreased the level of DOPAC but increased that of HVA in the striatum 60 min after the administration. PCP also increased the HVA level in the midbrain and cortex in a dose dependent fashion 60 min after the injection. On the other hand, chronic treatment of PCP produced a significant increase of the striatal DA level but 24 and 48 hr withdrawal from PCP decreased the DOPAC levels in the striatum and cortex. In the midbrain, the DA level was decreased but HVA level was significantly increased in the chronic PCP treated group. However, the increment of HVA levels in the acute experiment was no longer observed in the striatum and cortex. These results suggest that the pharmacological actions of PCP and tolerance development to PCP may be related to the functional changes of dopaminergic neuronal activity.",
author = "Toshitaka Nabeshima and M. Hiramatsu and M. Amano",
year = "1983",
month = "1",
day = "1",
language = "English",
volume = "4",
pages = "273--287",
journal = "Research Communications in Substances of Abuse",
issn = "0193-0818",
publisher = "PJD Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Effects of acute and chronic administration of phencyclidine on the levels of dopamine and metabolites in discrete brain areas of mouse

AU - Nabeshima, Toshitaka

AU - Hiramatsu, M.

AU - Amano, M.

PY - 1983/1/1

Y1 - 1983/1/1

N2 - The effects of phencyclidine (PCP) on the levels of dopamine (DA) and metabolites in discrete brain areas of mouse were investigated. In acute experiment, PCP significantly decreased the level of DOPAC but increased that of HVA in the striatum 60 min after the administration. PCP also increased the HVA level in the midbrain and cortex in a dose dependent fashion 60 min after the injection. On the other hand, chronic treatment of PCP produced a significant increase of the striatal DA level but 24 and 48 hr withdrawal from PCP decreased the DOPAC levels in the striatum and cortex. In the midbrain, the DA level was decreased but HVA level was significantly increased in the chronic PCP treated group. However, the increment of HVA levels in the acute experiment was no longer observed in the striatum and cortex. These results suggest that the pharmacological actions of PCP and tolerance development to PCP may be related to the functional changes of dopaminergic neuronal activity.

AB - The effects of phencyclidine (PCP) on the levels of dopamine (DA) and metabolites in discrete brain areas of mouse were investigated. In acute experiment, PCP significantly decreased the level of DOPAC but increased that of HVA in the striatum 60 min after the administration. PCP also increased the HVA level in the midbrain and cortex in a dose dependent fashion 60 min after the injection. On the other hand, chronic treatment of PCP produced a significant increase of the striatal DA level but 24 and 48 hr withdrawal from PCP decreased the DOPAC levels in the striatum and cortex. In the midbrain, the DA level was decreased but HVA level was significantly increased in the chronic PCP treated group. However, the increment of HVA levels in the acute experiment was no longer observed in the striatum and cortex. These results suggest that the pharmacological actions of PCP and tolerance development to PCP may be related to the functional changes of dopaminergic neuronal activity.

UR - http://www.scopus.com/inward/record.url?scp=0020991522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020991522&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0020991522

VL - 4

SP - 273

EP - 287

JO - Research Communications in Substances of Abuse

JF - Research Communications in Substances of Abuse

SN - 0193-0818

IS - 4

ER -